Skip to main content

Table 1 Patient characteristics at diagnosis according to use of antidepressants before cancer diagnosis

From: Preadmission antidepressant use and bladder cancer: a population-based cohort study of stage at diagnosis, time to surgery, and surgical outcomes

 

Non-users

AD users

n

%

n

%

Total

9348

89.7

1079

10.3

Median age (IQR) (years)

72.5

66.0–79.8

74.4

67.8–82.3

Age group (years)

 18–49

224

2.4

22

2.0

 50–59

814

8.7

85

7.9

 60–69

2554

27.3

235

21.8

 70–79

3475

37.2

378

35.0

 80-

2281

24.4

3539

33.3

Sex

 Male

7036

75.3

647

60.0

 Female

2312

24.7

432

40.0

Marital status

 Married

5549

59.4

532

49.3

 Widowed

1836

19.6

320

29.7

 Divorced

1233

13.2

145

13.4

 Never married

730

7.8

82

7.6

Charlson Comorbidity Index score

 Low (0)

4703

50.3

334

31.0

 Medium (1–2)

3124

33.4

437

40.5

 High (3+)

1521

16.3

308

28.5

Alcohol-related disorders

191

2.0

68

6.3

Year of cancer diagnosis

 2005–2007

2563

27.4

271

25.1

 2008–2010

2555

27.3

283

26.2

 2011–2013

2527

27.0

314

29.1

 2014–2015

1703

18.2

211

19.6

Stage of cancer at diagnosis

 Non-muscle-invasive (pT1)

3538

37.8

423

39.2

 Muscle-invasive (pT2+)

3854

41.2

437

40.5

 Missing

1956

20.9

219

20.3

Cystectomy

2370

25.4

162

15.0

 Neoadjuvant chemotherapy

222

9.4

15

9.3

Intended curative radiation therapy

1145

12.3

114

10.6

  1. All patients (n = 10,427) were diagnosed with incident invasive bladder cancer during 2005 through 2015. AD antidepressant, IQR interquartile range